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A B S T R A C T
Background: An enteroatmospheric ﬁstula (EAF) is a known, morbid complication of open abdomen
(OA) treatment. Patients with EAF often require repeated operations and long-lasting hospitalization. The
goal is to reach prompt closure of both the ﬁstula and the OA to avoid further morbidity and mortality.
This study describes and analyzes the treatment of EAFs in our clinic and aims at clarifying the factors
contributing to the outcome.
Materials and Methods: This study was carried out as a single-institution retrospective chart analysis
of patients treated with an OA and EAF at our institute between years 2004 and 2014. Twenty-six pa-
tients were included in the analysis.
Results: Twenty-three (88%) of the EAFs were primarily managed surgically: 14 with suturing and 9 with
resection and/or stoma. From the latter group two died 1 and 2 days, respectively, after surgery. Of the
remaining 21 patients, EAF recurred in 12/14 (86%) patients after suturing whereas in only 3/7 (43%)
patients after resection and/or stoma (p = 0.04). Among the 21 early survivors after EAF repair, four pa-
tients reached fascial closure simultaneously with the EAF repair. Of the rest 9/17 had Bogota bag or drapes
as temporary abdominal closure and 8/17were treatedwith vacuum assisted closure device with or without
fascial traction by mesh. All the nine patients treated with non-negative pressure dressings developed
recurrence but only 4/8 in the negative-pressure treated group (p < 0.02). All conservatively treated pa-
tients developed persistent EAF. The overall in-hospital mortality rate was 35% (9/26).
Conclusion: Surgical repair of EAF has a high failure rate. Primary resection of the affected region appears
to be themost successful approach to avoid EAF recurrence. Furthermore, negative pressure wound therapy
is superior to non-negative-pressure solutions in relation to EAF recurrence.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Open abdomen (OA) is an eﬃcient means to treat and follow
up critically ill patients with abdominal hypertension (IAH) or ab-
dominal compartment syndrome (ACS) [1–3]. The goal is to reach
prompt primary fascial closure, for the longer the OA treatment, the
more common are the complications [4,5]. The well-known problem
with prolonged OA is the development of adhesions, scarring, lat-
eralization of the abdominal wall and ﬁnally frozen abdomen [6].
This course of events predisposes also to the development of
enteroatmospheric ﬁstulae (EAF), which are considered as parts of
this vicious circle. The Classiﬁcation of Open Abdomen [7] was de-
signed to improve the management of patients with OA and it
describes these phenomena in detail.
The factors predisposing to the development of EAFs are not clear.
There are a few studies attaching abdominal sepsis to a higher in-
cidence of EAFs [8,9]. In trauma patients treated with OA the
incidence of EAFs has been associated with large-volume resusci-
tation and an increasing number of re-explorations [10]. Negative
pressure wound therapy (NPWT), also used to treat an EAF, is linked
to their development in 5% of patients [11]. Earlier reports have re-
vealed the incidence of EAFs to approximate 20% during NPWT
[12,13]. The etiology of an EAF may often be multifactorial and rep-
resent a combination of several independent factors including the
primary diagnosis and cause for OA treatment, iatrogenic lesions
of the intestinal tract during laparostomy/relaparotomy, postoper-
ative anastomotic rupture, dehydration, swelling and ischemia of
the intestine, exposure of the bowel to materials used for tempo-
rary abdominal closure (TAC), adhesions between the bowel and the
abdominal wall, wound infections [11]. In line with these data, the
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incidence of EAFs has been described to be highest among pa-
tients with abdominal sepsis and pancreatic necrosis [14,15]. Overall
the incidence of EAFs varies between 5 and 75% in OA patients
[16].
The aim of this study was to assemble and analyze the patients
treated for OA and EAF in our clinic. We describe the management
of these patients and aim at clarifying possible factors predicting
the outcome.
2. Material and methods
This study was carried out as a single institution retrospective
chart analysis of patients treated with an open abdomen and
enteroatmospheric ﬁstulae at our institute between years 2004 and
2014. The inclusion criterion was diagnosis of an EAF within the
studied time period. Exclusion criteria were other existing
enterocutaneous ﬁstulae and tumor ﬁstulae. Altogether 229 pa-
tients were treated for open abdomen during this time interval.
Thirty patients met the inclusion criteria. Three of these were either
pre- or postoperatively treated in another hospital and had thus in-
complete records and were excluded from the analysis. One trauma
patient was hospitalized for over two years and had altogether 150
operations of which several had extra-abdominal targets. This patient
was excluded due to impalpable and rambling data.
2.1. OA classiﬁcation
The open abdomen was characterized at the ﬁrst diagnosis of
an EAF. The amended classiﬁcation system of the open abdomen
was used [17]. Brieﬂy, the status of open abdomen is divided into
four classes according to the stage of ﬁxation (1 to 3) and contam-
ination (A to C). Number 4 represents established EAF in a frozen
abdomen.
2.2. Temporary abdominal closure (TAC)
Vacuum and mesh mediated fascial traction (VACM) was used
for 13 patients as TAC prior to the EAF diagnosis. The other half (13
patients) had either Bogota bag or surgical drapes to temporarily
seal the abdomen.
VACMmethodology has been previously described by Petersson
et al. in 2007 [18] and we have reported it to result in high fascial
closure rate after OA [19]. In brief, the commercially available VAC
system (V.A.C.® Abdominal dressing system, KCI, San Antonio, Texas;
USA) was used. First, the intra-abdominal contents were covered
by a polyethylene sheet. An oval-shaped polypropylene mesh was
then sutured to the fascial edges and covered with a polyurethane
sponge and ﬁnally with occlusive sheets. This systemwas then con-
nected to a suction apparatus creating continuous topical negative
pressure (125 mmHg).
TAC changes were performed every two to three days in the op-
erating theater or bedside at the intensive care unit. For VACM
patients, the mesh was divided in midline at the ﬁrst TAC change
and then tightenedwith continuous suturing after replacing the inner
polyethylene sheet with a sterile one.
2.3. Method of EAF repair
In cases of twenty-three patients, all the diagnosed EAFs were
primarily managed operatively. The methods were direct suturing
of the opening of the ﬁstula with absorbable 4/0 or 3/0 sutures, re-
section of the affected bowel loop and/or preparation of a stoma.
Three patients were treated conservatively for their EAFs. One was
primarily managed with an intraluminally inserted percutaneous
gastrostoma system (PEG) and twoweremerely followed up because
of minimal leakage.
2.4. Statistical analysis
Statistical analyses were performed using IBM® SPSS® Statis-
tics version 19 for Windows® (Armonk, New York, USA). Fisher’s
exact test was used for comparison of subgroups.
3. Results
3.1. Patient characteristics
Twenty-six patients treated with OA and EAF were included in
the analysis. The detailed patient characteristics are described in
Tables A.1 and A.2. Twenty-ﬁve (96%) patients represented with at
least one chronic illness. Eighteen (69%) patients had been through
a previous laparotomy before the index hospitalization period and
eighteen (69%)patients had at least one antecedent laparotomy done
before laparostomy during the index period. 0–6 (mean 2) opera-
tions were performed during OA therapy before the ﬁrst EAF
diagnosis. 50% had negative pressure wound therapy (VACM) as TAC.
The duration of OA treatment before EAF diagnosis varied from zero
to 23 days (mean 7) and as a whole from ﬁve to 140 (mean 18) days.
The length of hospitalization period varied from six to 87 (mean
29) days.
3.2. EAFs location and number
The twenty-six patients were diagnosed with altogether 56 EAFs.
Thirteen (50%) patients were diagnosed with one and the rest (50%)
with two to ﬁve (mean two) EAFs. More accurate location of the
ﬁstulae is described in Table A.2.
In 69% of cases the EAF was found at an anastomosis or at a
serosal defect. 31% had their EAFs detected at a previously healthy
bowel. (Table A.2)
3.3. OA and EAF-related supportive care
Twenty-one (81%) patients were admitted to the ICU during the
index hospitalization period and stayed there for 5 to 56 (mean 24)
days. Twenty-three (88%) patients were treated with total paren-
teral nutrition (TPN) and nine (35%) patients were administered
octreotide in order to reduce the eﬄuent volume. Sixteen (62%) pa-
tients received iv blood products. Vasoactive support was needed
in 73% (19/26) of cases and temporary renal replacement therapy
in 35% (9/26).
3.4. EAF repair
3.4.1. Surgery
Primary surgical repair of all diagnosed EAFs was chosen for
twenty-three (88%) patients at the diagnosis of an EAF. All these OAs
were classiﬁed as either 1C or 2C. Fourteen of these were managed
with direct suturing of the ﬁstulae. Eight patients underwent bowel
resection and for ﬁve of these (5/8) also an ileo- or colostoma was
prepared. One patient was managed by ileostomy only.
2/9 patients managed with resection/stoma died of MODS 1–2
days after EAF repair. Among the seven survivors a recurrent EAF
was diagnosed in three cases (43%). In contrast, 12/14 (86%) pa-
tients in the group of direct suturing developed a recurrent EAF
(p = 0.04).
Altogether ﬁfteen recurrences were diagnosed after surgical EAF
repair. Ten of these (33%) were managed operatively with a success
rate of (6/10) 60%. (Fig. A.1.) 3/10 died: two due to relapsing EAFs
and severe infections and one drifted into prolonged ICU-care,
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impaired healing and perished. 1/10 developed a persistent EAF,
whichwas later repaired in a reconstructive operation after 6months.
Five (5/15) recurrences were treated conservatively. All these pa-
tients developed a persistent EAF and three (3/5) died because of
that. (Fig. A.1) Both of the two survivors reached secondary recon-
struction after 11 to 17 (mean 14) months.
Of all the twenty-three surgically treated patients ﬁfteen (65%)
survived. Of this group three (20%, 3/15) patients ended up with a
persistent EAF, which were all reconstructed later. 9/15 patients
reached abdominal closure and for the remaining 6/15 patients skin
grafts were positioned to cover the viscera. These six patients in-
cluded those three with persistent EAFs.
3.4.2. Conservative treatment
For three (3/26) patients a non-surgical approach was chosen pri-
marily. (Fig. A.1) Two of these OAs were classiﬁed as grade 4 and
one as grade 2C at the diagnosis of an EAF. Two patients had no spe-
ciﬁc treatment for their EAFs due to minimal leakage and uncertain
location of the defect. One patient was treated with a percutane-
ous gastrostomy (PEG) system inserted intraluminally through the
EAF and tightened against the abdominal wall.
One patient managed by follow-up died due to persistent in-
fection of uncertain origin. The other was transferred to another
hospital for further care with unknown outcome. The patient treated
with PEG was left with a persistent EAF, but reached abdominal
closure and was discharged. Later-on he went through an attempt
of endoscopic closure but died shortly after that acutely of cardiac
reasons.
3.5. TAC and EAF recurrence
In the group of the twenty-three surgically treated patients twelve
(52%) had a plastic silo (Bogota bag) or surgical drapes as TAC and
eleven (48%) were managed with VACM prior to the EAF diagno-
sis. In the latter group two patients died 1–2 days after EAF repair
andwere excluded from further analysis. 11/12 patients treated with
Bogota bag or drapes developed a recurrent EAF whereas only 4/9
patients in the VACM-group did (p = 0.02).
In the group of the twenty-one early survivors after EAF repair,
four (19%) patients reached fascial closure simultaneously with EAF
repair. Two (2/4) of these developed a recurrent EAF: one after a
newly established ACS and laparostomy and the other had an enteric
leak via silicon tube drainage after fascial closure which thus ac-
tually represented an enterocutaneous ﬁstula. The former patient
was managed operatively by suturing and survived. The latter was
treated conservatively and died of persistent ﬁstula and MODS.
Of the rest, nine (9/17, 53%) had Bogota bag or drapes as TAC and
ten (8/17, 47%) were treated with VAC/VACM. All the nine pa-
tients (100%) treatedwith non-negative pressure dressings developed
a recurrent EAF whereas only 4/8 (50%) in the negative-pressure
treated group were diagnosed with recurrence (p < 0.02).
3.6. Mortality
Altogether nine (35%) patients died during index hospitaliza-
tion period due to OA related reasons. The causes of death were
persistent EAF (four patients), other severe infective complica-
tions (two patients) andmulti-organ-dysfunction-syndrome (MODS)
(three patients). Six (23%) patients died with OA.
In the group of patients with OA duration under 7 days prior to
the EAF the mortality was 3/15 (20%). Among those treated for OA
over one week prior to the EAF, the mortality was 6/11 (55%),
(p = 0.067).
4. Discussion
This study corroborates the previous conception of antecedent
abdominal surgery predisposing to the development of complica-
tions during OA management. Furthermore, our patient population
representing 70% peritonitis and 35% in-hospital mortality, well re-
ﬂects other studies reporting overall worse outcome with higher
mortality, increased complications and lower facial closure rates in
secondary peritonitis compared to trauma treated with OA [15,20].
We observed resection or stoma preparation to be superior to plain
suturing in effort to avoid EAF recurrence. Also topical negative-
pressure solutions were shown preferable in comparison to non-
negative dressings as TAC in order to avoid EAF relapse. In line with
previous observations on the duration of OAmanagement, we show
a trend toward increased mortality after OA treatment longer than
seven days prior to the EAF diagnosis.
Open abdomen (OA) management is of irreplaceable value when
treating or preventing abdominal compartment syndrome (ACS) after
trauma or damage control surgery [21,22]. Its role has recently grown
in the management of severe peritonitis and it is increasingly used
as a follow-up tool in cases of planned reoperations or in patients
with compromised intestinal circulation [23,24]. Excluding trauma
patients, the conditions leading to increased intra-abdominal pres-
sure often associatewith a critically fading general state of the patient
and a need for long-lasting ICU care. This combination is a favor-
able platform for the development of various complications.
One of the most devastating complications in an open abdomen
is a ﬁstula between the bowel and the atmosphere (EAF). These
appear especially in the course of prolonged OA treatment which
predisposes to the development of intra-abdominal adhesions and
ﬁnally frozen abdomen [7,25]. All manipulation of the fragile intra-
abdominal contents, including TAC changes, is considered as a
potential risk factor for iatrogenic bowel injury and thus an EAF [26].
In this study 77% of patients had gone through at least one lapa-
rotomy before laparostomy during the studied hospitalization period.
NPWT with continuous fascial traction has proven its role as an
eﬃcient means to reach primary fascial closure after OA
[18,19,27–29]. Atema et al. further reported NPWTwith fascial trac-
tion to have the lowest risk for EAF development in comparison to
NPWT or mesh inlay alone. On the contrary, in 2010 recommen-
dations were published in favor of choosing other TAC alternative
than NPWT with mesh after damage control surgery to avoid the
development of ﬁstula [30]. In 2014 Bruhin et al. [8] concluded
NPWT to be the best option currently available to treat Grade 3 OA
with an EAF. In our population approximately 50% of patients had
VAC/VACM as TAC both prior to and after EAF diagnosis and it as-
sociated with decreased EAF recurrence compared to non-negative
pressure dressings.
Themanagement of EAFs is diﬃcult and laborious. EAFs are char-
acterized by a lack of a real ﬁstula tract and surrounding soft tissue
which diminish the possibility of spontaneous healing [31,32]. Thus,
surgical interventions are usually needed. After recognition of an
EAF, the often hypercatabolic patient should ﬁrst be stabilized with
an aim at decreasing the ﬁstula output and correcting the ﬂuid im-
balance [11]. Means to diminish the eﬄuent include total parenteral
nutrition, somatostatin analogs and proton pump inhibitors [33].
The second step in EAF management is classiﬁcation and decision
making on further treatment. Only after that the deﬁnitive surgery
takes place [34]. DiSaverio et al. [35] have recently published an al-
gorithm on surgical management. It takes into account the amount
of ﬁstula eﬄuent, the number of ﬁstulae and whether the patient
suffers from ongoing peritonitis or not. Many treatment options have
been described. The conventional strategies: suturing, bowel re-
section or proximal diversion are sometimes preceded or totally
replaced by one of the many VAC-solutions. These are at times used
in combination with biologic dressings in order to seal the ﬁstula
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opening and promote its closure [36]. We report a ﬁnal success rate
of 80% with surgical approach as ﬁrst-line therapy among survi-
vors. The conservative means resulted in EAF persistence in 100%.
EAFs are not only harmful for the patients and laborious for the
surgeons but they also create a heavy ﬁnancial burden for the society
by increasing the ICU stay by three-fold, the hospital stay by four-
fold and the hospital charges by four and a half-fold [37]. The onset
of the vicious circle leading to a hostile abdomen should be pre-
vented in time by prompt abdominal closure [38]. In case of an EAF
diagnosis, effective control of the eﬄuent volume and spillage fol-
lowed by timely surgical management is recommended to avoid
prolonged ICU treatment. EAF-related mortality is high, 30–60% ac-
cording to the literature [39–42]. In our series, the incidence of EAF
among OA patients during the studied time periodwas (30/229) 13%.
35% of patients died which is in line with previous reports consid-
ering our critically ill patient population.
5. Conclusions
The development of EAFs seems to be associated with a history
of previous abdominal surgery. Primary resection of the affected
region and preparation of a stoma appear to be the most success-
ful approaches to avoid EAF recurrence. Furthermore, negative
pressure wound therapy is signiﬁcantly more eﬃcient compared to
non-negative-pressure solutions in relation to EAF recurrence. The
length of the OA treatment seems to be associated with mortality.
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Appendix
Table A.1
Patient characteristics, N = 26.
Age years (mean, range) 61 (36–80)
Sex ratio (male) 20 (77 %)
Diagnosis
Peritonitis 18 (69%)
Aortic pathology (RAAAa/dissection) 6 (23%)
Trauma 1 (4%)
Other (paralytic ileus) 1 (4%)
Chronic illnesses
Elevated blood pressure 15 (58%)
Obesity 9 (35%)
Dyslipidemia 6 (23%)
Alcoholism 6 (23%)
Asthma/COPDb 5 (19%)
Psychiatric condition 5 (19%)
Diabetes 4 (15%)
Coronary disease 4 (15%)
Active malignancy 3 (12%)
Colitis ulcerosa 3 (12%)
Arterial sclerosis 3 (12%)
Rheumatoid disease 2 (8%)
Cardiac failure 2 (8%)
Prostatic hyperplasia 2 (8%)
Chronic pancreatitis 1 (4%)
Renal failure and dialysis 1 (4%)
Epilepsy 1 (4%)
a RAAA = ruptured abdominal aortic aneurysm.
b COPD = chronic obstructive pulmonary disease.
Table A.2
Patient characteristics, N = 26.
Indication for laparostomy
ACSa 7 (27%)
Inability to close the abdomen 8 (31%)
Prophylactic 11 (42%)
Classiﬁcation of open abdomen
1C 4 (15%)
2C 20 (77%)
4 2 (8%)
TACb before EAFc
Bogota bag/surgical drapes 13 (50%)
VACM 13 (50%)
TAC after EAF
Bogota bag/surgical drapes 9 (47%)
VAC/VACM 10 (53%)
Open abdomen duration pre EAF
0–7 days 15 (58%)
Over 7 days 11 (42%)
EAF location
Normal intestine 8 (31%)
Anastomosis 14 (54%)
Serosal defect 4 (15%)
Small bowel 17 (65%)
Large bowel 3 (12%)
Gastric 1 (4%)
Small bowel + gastric 2 (8%)
Small bowel + large bowel 3 (12%)
Laparotomies at the index hospitalization period
(before laparostomy)
0 6 (23%)
1 15 (58%)
2 or more 5 (19%)
Previous laparotomies (before index period)
0 8 (31%)
1 8 (31%)
2 or more 10 (38%)
a ACS = abdominal compartment syndrome.
b TAC = temporary abdominal closure.
c EAF = enteroatmospheric ﬁstula.
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